Literature DB >> 33624604

[MiR-300 inhibits invasion and metastasis of osteosarcoma cell MG63 by negatively regulating PTTG1].

D Liang1, X Wu1, J Bai2, L Zhang2, C Yin3, W Zhong1.   

Abstract

OBJECTIVE: To investigate the effects of miR-300 and PTTG1 on osteosarcoma invasion and metastasis and explore the molecular mechanism of osteosarcoma invasion and metastasis.
OBJECTIVE: Western blot was used to detect the expression of PTTG1 in human osteoblasts hFOB1.19 and osteosarcoma cell MG63 and to detect the transfection efficiency of cells transfected with PTTG1-knockdown plasmid; Transwell invasion assay and CCK8 assay detected the effects of knockdown of PTTG1 and overexpression of miR-300 on the invasion and proliferation of osteosarcoma cell MG63. On-line prediction and screening of microRNAs (miRNAs) with complementary PTTG1 binding was conducted. qRT-PCR was performed to examine the expression of miR-300 in hFOB1.19 and MG63 cells, and Western blotting was used to detect the expression of PTTG1 in MG63 cells after transfection with a miR- 300 plasmid. Double luciferase assay was used to detect the targeted binding of miR-300 and PTTG, Transwell invasion assay and CCK8 assay were used to detect the effects of overexpression of miR-300 and overexpression of PTTG1 plasmid on invasion and proliferation of osteosarcoma cell line MG63.
OBJECTIVE: PTTG1 was highly expressed in MG63 cells (P=0.0002). PTTG1 knockdown significantly inhibited the invasion (P=0.0002) and proliferation (P=0.0039) of MG63 cells. Based on the results of online prediction of complementary miRNAs to PTTG1 and analysis of the data from NCBI database, miR-300 was determined as the target miRNA in this study. qRT-PCR results showed a significantly decreased expression of miR-300 in MG63 cells (P=0.0004). Overexpression of MiR-300 in MG63 cells significantly decreased the expression of PTTG1 (P=0.0007), and the expressions of miR-300 and PTTG1 were negatively correlated. Dual luciferase assay showed that miR-300 could specifically bind to PTTG1 (P=0.001). Overexpression of PTTG1 could significantly reverse the effect of miR-300 overexpression on invasion (P=0.0003) and proliferation (P=0.0077) of MG63 cells.
OBJECTIVE: Overexpression of miR-300 can inhibit the invasion and metastasis of osteosarcoma cell MG63 by targeting PTTG1.

Entities:  

Keywords:  PTTG1; invasion; metastasis; miR-300; osteosarcoma; proliferation

Mesh:

Substances:

Year:  2021        PMID: 33624604      PMCID: PMC7905244          DOI: 10.12122/j.issn.1673-4254.2021.02.18

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  25 in total

1.  MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R.

Authors:  Yong Zhang; Sanxiu Huang; Yu Guo; Lingfeng Li
Journal:  Biomed Pharmacother       Date:  2018-07-23       Impact factor: 6.529

2.  Identification of a vertebrate sister-chromatid separation inhibitor involved in transformation and tumorigenesis.

Authors:  H Zou; T J McGarry; T Bernal; M W Kirschner
Journal:  Science       Date:  1999-07-16       Impact factor: 47.728

3.  MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.

Authors:  Tongle Zhi; Kuan Jiang; Xiupeng Xu; Tianfu Yu; Weining Wu; Er Nie; Xu Zhou; Xin Jin; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

4.  Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark D Krailo; John H Healey; Mark L Bernstein; Donna Betcher; William S Ferguson; Mark C Gebhardt; Allen M Goorin; Michael Harris; Eugenie Kleinerman; Michael P Link; Helen Nadel; Michael Nieder; Gene P Siegal; Michael A Weiner; Robert J Wells; Richard B Womer; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

5.  Dock1 promotes the mesenchymal transition of glioma and is modulated by MiR-31.

Authors:  Baogang Zhang; Hongli Li; Chonggao Yin; Xuemei Sun; Shuxian Zheng; Changjie Zhang; Lihong Shi; Yuqing Liu; Shijun Lu
Journal:  Neuropathol Appl Neurobiol       Date:  2016-04-28       Impact factor: 8.090

6.  Identification of Dormancy-Associated MicroRNAs for the Design of Osteosarcoma-Targeted Dendritic Polyglycerol Nanopolyplexes.

Authors:  Galia Tiram; Ehud Segal; Adva Krivitsky; Rony Shreberk-Hassidim; Shiran Ferber; Paula Ofek; Taturo Udagawa; Liat Edry; Noam Shomron; Maayan Roniger; Batsheva Kerem; Yuval Shaked; Sarit Aviel-Ronen; Iris Barshack; Marcelo Calderón; Rainer Haag; Ronit Satchi-Fainaro
Journal:  ACS Nano       Date:  2016-02-08       Impact factor: 15.881

Review 7.  Osteosarcoma Overview.

Authors:  Brock A Lindsey; Justin E Markel; Eugenie S Kleinerman
Journal:  Rheumatol Ther       Date:  2016-12-08

8.  Identification of Serum miRNA-423-5p Expression Signature in Somatotroph Adenomas.

Authors:  Sida Zhao; Jianhua Li; Jie Feng; Zhenye Li; Qian Liu; Peng Lv; Fei Wang; Hua Gao; Yazhuo Zhang
Journal:  Int J Endocrinol       Date:  2019-07-17       Impact factor: 3.257

9.  miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.

Authors:  Jingshuang Yu; Furong Xie; Xin Bao; Wantao Chen; Qin Xu
Journal:  Mol Cancer       Date:  2014-05-24       Impact factor: 27.401

10.  PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis.

Authors:  Yonggang Wang; Fangshi Hao; Yonghao Nan; Licheng Qu; Wanli Na; Chunshu Jia; Xiaoliang Chen
Journal:  Int J Biol Sci       Date:  2018-10-20       Impact factor: 6.580

View more
  2 in total

1.  MicroRNA Alterations Induced in Human Skin by Diesel Fumes, Ozone, and UV Radiation.

Authors:  Giuseppe Valacchi; Erika Pambianchi; Simona Coco; Alessandra Pulliero; Alberto Izzotti
Journal:  J Pers Med       Date:  2022-01-28

2.  MicroRNA-300 Inhibits the Proliferation and Metastasis of Cervical Cancer Cells via Posttranscriptional Suppression of G Protein-Coupled Receptor 34 (GPR34).

Authors:  Mei Wang; Ying Tian; Lin Miao; Wenxia Zhao
Journal:  J Oncol       Date:  2021-12-14       Impact factor: 4.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.